- Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
-
Lee HY, Jun DW, Kim HJ, Oh H, Saeed WK, Ahn H, Cheung RC, Nguyen MH
- KMID: 2441009
- Korean J Intern Med.
- 2019 Mar;34(2):296-304.
- doi: 10.3904/kjim.2017.194
BACKGROUND/AIMS: A number of clinical trials reported varying effects of cholesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We, therefore, assessed the changes in hepatic steatosis and NAFLD... -
- CITED
-
- Close
- SHARE
-
- Close
